AMPHENOL CORP /DE/
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $23.1B | $15.2B | $12.6B | $12.6B | $10.9B |
| Cost of revenue | $14.6B | $10.1B | $8.5B | $8.6B | $7.5B |
| Gross profit | $8.5B | $5.1B | $4.1B | $4.0B | $3.4B |
| Selling, general & administrative | $2.5B | $1.9B | $1.5B | $1.4B | $1.2B |
| Research and development | $647.0M | $453.0M | $342.2M | $323.6M | $317.7M |
| Operating income | $5.9B | $3.2B | $2.6B | $2.6B | $2.1B |
| Interest expense | $367.8M | $217.0M | $139.5M | $128.4M | $115.5M |
| Pretax income | $5.6B | $3.0B | $2.5B | $2.5B | $2.0B |
| Income tax expense | $1.3B | $570.3M | $509.3M | $550.6M | $409.1M |
| Net income | $4.3B | $2.4B | $1.9B | $1.9B | $1.6B |
| Balance Sheet | |||||
| Cash and equivalents | $11.1B | $3.3B | $1.5B | $1.4B | $1.2B |
| Current assets | $20.3B | $9.7B | $6.8B | $6.5B | $6.0B |
| Total assets | $36.2B | $21.4B | $16.5B | $15.3B | $14.7B |
| Current liabilities | $6.8B | $4.1B | $3.2B | $2.7B | $2.4B |
| Total liabilities | $22.7B | $11.6B | $8.1B | $8.2B | $8.3B |
| Stockholders' equity | $13.4B | $9.8B | $8.3B | $7.0B | $6.3B |
| Cash Flow Statement | |||||
| Cash from operations | $5.4B | $2.8B | $2.5B | $2.2B | $1.5B |
| Depreciation and amortization | $922.4M | $572.5M | $406.4M | $392.9M | $395.6M |
| Stock-based compensation | $135.4M | $109.5M | $99.0M | $89.5M | $83.0M |
| Capital expenditure | $996.6M | $665.4M | $372.8M | $383.8M | $360.4M |
| Free cash flow | $4.4B | $2.1B | $2.2B | $1.8B | $1.2B |
| Dividends paid | $802.2M | $595.1M | $500.6M | $477.4M | $346.7M |
| Share repurchases | $665.2M | $689.3M | $585.1M | $730.5M | $661.7M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 1.2B · Free float 98.5%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.